defici serum carboxypeptidas blike anaphylatoxin inactiv carboxypeptidas n activ sera patient cystic fibrosi serum 95 patient cystic fibrosi 47 control subject without cystic fibrosi analyz carboxypeptidas blike activ presenc optim concentr co2 ion hippurylllysin serum fourteen cystic fibrosi patient steatorrhea therefor minim pancreat dysfunct patient cystic fibrosi control compar age serum carboxypeptidas blike activ significantli decreas cystic fibrosi patient includ cystic fibrosi patient without steatorrhea significantli low valu found male femal cystic fibrosi patient compar control similar sex although valu unaffect age control popul valu older patient cystic fibrosi significantli lower valu younger patient correl obtain serum carboxypeptidas blike activ pulmonari hepat function serum carboxypeptidas blike activ therefor fall progress diseas may limit abil degrad circul peptid older patient cystic fibrosi defici serum carboxypeptidas blike activ less like howev factor develop earli manifest diseas